Latisse



Get Ready for an Innovation in Lashes

Latisse® is the first and only prescription treatment approved by the FDA for inadequate or not enough eyelashes, growing them longer, fuller and darker.

Latisse® is FDA approved and effective. It’s a once-a-day treatment you apply topically to the base of your upper eyelashes. Patients in a clinical trial saw results in as few as 8 weeks with full results after 12 to 16 weeks.

While Latisse® is a treatment for inadequate or not enough eyelashes, it was developed through years of research by Allergan, a pharmaceutical leader with over 60 years of expertise in prescription eye care products.

Latisse® (Bimatoprost Ophthalmic Solution) 0.03% Important Information

Latisse® is an FDA-approved treatment to grow eyelashes for people with inadequate or not enough lashes.

Approved Use

Important Safety Information

If you use/used prescription products for eye pressure problems, use Latisse® under doctor care. May cause brown darkening of the colored part of the eye which is likely permanent. Latisse® may cause eyelid skin darkening which may be reversible. Only apply at base of upper lashes. Do not apply to lower lid. Hair may grow outside the treatment area. If you have eye problems/surgery, consult your doctor. Common side effects include itchy and red eyes. If discontinued, lashes gradually return to previous appearance.

To report a side effect, please call Allergan at 1-800-433-8871.

Please see Latisse® full Product Information.

Latisse-Product-Image

latisse-BA-top-view
latisse-BA-side-view
latisse-BA-front-view

Search